Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
897.55
6.00
(0.67%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Cadila Healthcare - Quaterly Results
>>
Cadila Healthcare - Quaterly Results
>>
Cadila Healthcare trades higher on the BSE
>>
Cadila Healthcare informs about press release
>>
Zydus Cadila supplies first consignment of Covid-19 vaccine ‘ZyCoV-D’
>>
Cadila Healthcare informs about conference call
>>
Cadila Healthcare informs about press release
>>
Cadila Healthcare informs about board meeting
>>
Zydus Cadila receives USFDA’s final approval for Vigabatrin Tablets
>>
Cadila Healthcare informs about certificate
<<
<
69
70
71
...168
>
>>